Replies to post #110785 on Avid Bioservices Inc (CDMO)

[wxcbs]

Yep...agreed. Too much irrational exhuberance.

[chenzo11]

Agreed, just look at the chart. We can't even get through $2.25. today we'll most likely test $2.00.

I find it hard to believe we at Ihub are the only ones who know "this best kept secret". It either does or does not work. At this moment, Wall street is saying it doesn't.

If Bavi is a total bust, we are at .40; If it is as successful as we feel, $50+. I feel the reward far outweighs the risk. But then I ask myself, why are we struggling to stay above $2.00? Does someone know something we don't. As retail investors, we are the last to know. In PPHM case, are we the first to know?

Let's get through $2.25, then $3.00, then $5.00 before we get all lathered up.

[newbieee]

I agree.

[bimerkjaere]

Agreed, to be consider for breakthrough therapy or an accelerated approval, I would presume you would need stronger data than what the final 2nd-line results will provide. Perhaps I am wrong, but we likely lost our opportunity of a near-term approval after the discrepancies were found. A fantastic pancreatic result could change this, but this trial seems too small for the FDA to be convinced (IMO).